Clinical Trials Browser

Phase 1/2 × INDUSTRY × Diphenhydramine × Clear all

NCT01455389 2022-03-02

TUSC2-nanoparticles and Erlotinib in Stage IV Lung Cancer

Phase 1/2 Terminated

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms